OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer


Recommended Conferences for Depressive disorder

Depressive disorder

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums

Depressive disorders generally consist of major depressive disorder (MDD), dysthymia, and minor depression. Major depressive disorder is a broad and heterogeneous condition associated with a range of cognitive, behavioural, emotional, and physical symptoms. Central to major depressive disorder is low mood and/or loss of pleasure in most activities.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

Approximately 18.8 million American adults, or about 9.5 percent of the U.S. population age 18 and older in a given year, have a depressive disorder. Depression affects all people regardless of age, geographic location, demographic or social position. Depressive disorders are appearing earlier in life with the average age of onset 50 years ago being 29 whereas recent statistics indicate it at just 14.5yrs in today's society. The severity of the disorder may vary from mild to severe depending on both the number of symptoms and the degree of functional impairment. In severe cases, psychotic symptoms such as hallucination or delusion may be present. Major depressive disorder often has a remitting and relapsing course, and symptoms may persist between episodes. The rate of major depressive disorder in women is twice as high as in men. The routine use of antidepressants to treat mild major depressive disorder is not recommended except for those who have a past history of moderate or severe major depressive disorder or who have mild major depressive disorder that persists after other interventions.

List of Best International Conferences

List of Related Societies & Associations

  • American Psychiatric Association
  • Depression and Bipolar Support Alliance
  • Australian Psychological Society
  • Post and Antinatal Depression Association Inc
  • Anxiety and Depression Association of America
  • Canadian Mental Health Association
  • National Multiple Sclerosis Society
  • Psych Centrals – Dealing with Depression Related Stigma
  • Alzheimer’s society
  • The Guardian

List of Related Companies

  • Bristol – Myers Squibb (Serozone)
  • Forsest Pharmaceuticals (Celexa, Lexapro)
  • Wyeth (Effexor)
  • Solvay (Luvox)
  • Organon (Remeron)

A recent study sponsored by the World Health Organization and the World Bank found unipolar major depression to be the leading cause of disability in the United States. Women between the ages of 25-44 are most often affected by depression with a major cause of depression in women being the inability to express or handle Anger. More than a third of the Europe population suffers from some sort of a mental disorder each year. The London School of Economics estimated the total loss of output due to depression and chronic anxiety in the UK at some 12 billion pounds a year.

Depressive disorder is a mental disorder that involves the brain and is characterized by a pervasive and persistent low mood, feelings of guilt and poor concentration. Major depressive disorder (MDD) is also called as clinical depression, unipolar depression or recurrent depression. It is a type of disabling condition that that adversely affects a person's family, work or school life, sleeping and eating habits, and general health. Depression can result into complications like insomnia, excessive sleeping, fatigue, loss of energy, pains. People with depressive disorders have shorter life expectancies than those without depression because of their greater susceptibility to medical illnesses and suicide. Depression can be caused by damage to the cerebellum as is seen in cerebellar cognitive affective syndrome. Infectious diseases and neurological conditions like addison’s disease, lyme disease, multiple sclerosis, chronic pain, stroke, cancer are the different types of depressive disorders. Life events such as childbirth, menopause, financial difficulties, job problems, loss of a loved one, natural disasters, social isolation, relationship troubles etc can be the reason of depressive disorders. Substance-induced mood disorder resembling major depression is caused due to long-term drug use or drug abuse and also due to to withdrawal from certain sedative and hypnotic drugs.When the disorder is mild, it can be treated without medicines but when it is moderate or severe people may need medication for treatment. People are treated with antidepressant medication and in many cases also require counseling, cognitive behavioral therapy, talk therapy.

Depression and Anxiety disorders are caused due to abnormal variations in the mood of a person. Studies have reported that 90% of patients with anxiety disorders develop Depression. Thus to improve patient care scientists and researchers are integrating innovations and advanced technologies to prevent and treat depression and disorders related to it. Conferences, National symposiums and Workshops provide a dedicated forum for the advancement, execution and exchange of information about depressive and mood disorders. Around 40 National symposiums and Workshops are going to be held across the globe which includes “International Forum on Mood and Anxiety Disorders”, “2015 Ageing Summit”, “7th Clinical Trials on Alzheimer’s Disease”, “10th International Congress on Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders” and many more.
OMICS Group International is a pioneer and leading science event organizer, which publishes around 400 open access journals and conducts over 300 Medical, Clinical, Engineering, Life Sciences, Phrama International Conferences all over the globe annually with the support of more than 1000 scientific associations and 30,000 editorial board members and 3.5 million followers to its credit. As yet OMICS Group has organized 500 conferences, workshops and national symposiums across the major cities including San Francisco, Las Vegas, San Antonio, Omaha, Orlando, Raleigh, Santa Clara, Chicago, Philadelphia, Baltimore, United Kingdom, Valencia, Dubai, Beijing, Hyderabad, Bengaluru and Mumbai.

Relevant Conferences:

1. 2nd International Conference on Alzheimer's Disease and Dementia, September 23-25, 2014 , Spain (Omics Group)
2. 14th International Forum on Mood and Anxiety Disorders (IFMAD 2014) December 10-12, 2014 Vienna, Austria
3. 45th Annual Conference of the German Society for Genetics & 2nd International Parkinson's Disease Symposium, October 01- 04, 2014 Munsbach, Luxembourg
4. 7th Clinical Trials on Alzheimer’s Disease, November 20-22, 2014 Philadelphia, Pennsylvania
5. 12th International Conference on Alzheimer’s and Parkinson’s Diseases, March 18-22, 2015 Nice, France
6. 10th International Congress on Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders, December 4-7, 2014 Nice, France
7. 2015 Ageing Summit, February 10-12, 2015 London, United Kingdom
8. 2014 CHADD Annual International Conference on ADHD, November 13–15, 2014 Chicago, Illinois
9. 17th Annual Conference of the International Society for Bipolar Disorders, June 3-6, 2015 Toronto, Canada
10. 5th International Congress on ADHA 2015, May 28-31, 2015 Glasgow, United Kingdom
11. Anxiety and Depression Conference, April 9-12, 2015 Miami, Florida

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
+1-702-508-5200 Ext:8051

Program Enquiries
Media Partners | Advertising